SCHEMBL20676296

SCHEMBL20676296

Cc1ccnc(C2CCOC2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.42
CCR5 P51681 1/20 0.42
CCR8 P51685 1/20 0.42
OPRM1 P35372 1/20 0.40
OPRL1 P41146 1/20 0.40
PIK3CD O00329 2/20 0.39
PDE10A Q9Y233 2/20 0.39
PDE9A O76083 1/20 0.39
UHRF1 Q96T88 1/20 0.38
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MAP3K12 Q12852 1/20 0.37
MEN1 O00255 1/20 0.36
NOS3 P29474 1/20 0.36
NOS1 P29475 1/20 0.36
NOS2 P35228 1/20 0.36
KMT2A Q03164 1/20 0.36
ACVR2A P27037 1/20 0.36
TGFBR2 P37173 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14898047 0.90 PIK3CD (0.45) CCR1CCR5CCR8OPRM1OPRL1
SCHEMBL23365111 0.80 PIK3CD (0.36) PIK3CDKDM4EALDH1A1MAP3K12ACVR2A
SCHEMBL29979707 0.80 PIK3CD (0.36) PIK3CDMAP3K12ACVR2ATGFBR2PIK3CA
SCHEMBL23365116 0.80 PIK3CD (0.36) PIK3CDMAP3K12ACVR2ATGFBR2PIK3CA
SCHEMBL29979625 0.80 PIK3CD (0.36) PIK3CDKDM4EALDH1A1MAP3K12ACVR2A
SCHEMBL30997801 0.80 CCR1 (0.54) CCR1CCR5CCR8OPRM1OPRL1
SCHEMBL827860 0.80 CCR1 (0.54) CCR1CCR5CCR8OPRM1OPRL1
SCHEMBL14376103 0.80 NOS3 (0.41) PIK3CDKDM4EMAP3K12NOS3NOS1
SCHEMBL25147093 0.80 CHRNA7 (0.40) PIK3CDPDE9AMAP3K12ACVR2ATGFBR2
SCHEMBL14349682 0.80 MAP3K12 (0.37) PIK3CDMAP3K12ACVR2ATGFBR2PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019018795-A1 COMPOUNDS AND USES THEREOF YUMANITY THERAPEUTICS (US) 2019-01-24 WO disclosed